[Home]
[Full version]
Aggression as rewarding as sex, food and drugs
Jan 14 ,Medicine & Health
New research from Vanderbilt University shows for the first time that the brain processes aggression as a reward - much like sex, food and drugs - offering insights into our propensity to fight and our fascination with violent sports like boxing and football.
The research will be published online the week of Jan. 14 by the journal Psychopharmacology.
“Aggression occurs among virtually all vertebrates and is necessary to get and keep important resources such as mates, territory and food,” Craig Kennedy, professor of special education and pediatrics, said. “We have found that the ‘reward pathway’ in the brain becomes engaged in response to an aggressive event and that dopamine is involved.”
“It is well known that dopamine is produced in response to rewarding stimuli such as food, sex and drugs of abuse,” Maria Couppis, who conducted the study as her doctoral thesis at Vanderbilt, said. “What we have now found is that it also serves as positive reinforcement for aggression.”
For the experiments, a pair of mice - one male, one female - was kept in one cage and five intruder” mice were kept in a separate cage. The female mouse was temporarily removed, and an intruder mouse was introduced in its place, triggering an aggressive response by the “home” male mouse. Aggressive behavior included tail rattle, an aggressive sideways stance, boxing and biting.
The home mouse was then trained to poke a target with its nose to get the intruder to return, at which point it again behaved aggressively toward it. The home mouse consistently poked the trigger, which was presented once a day, indicating it experienced the aggressive encounter with the intruder as a reward.
The same home mice were then treated with a drug that suppressed their dopamine receptors. After this treatment, they decreased the frequency with which they instigated the intruder’s entry.
In a separate experiment, the mice were treated with the dopamine receptor suppressors again and their movements in an open cage were observed. They showed no significant changes in overall movement compared to times when they had not received the drugs. This was done to demonstrate that their decreased aggression in the previous experiment was not caused by overall lethargy in response to the drug, a problem that had confounded previous experiments.
The Vanderbilt experiments are the first to demonstrate a link between behavior and the activity of dopamine receptors in response to an aggressive event.
“We learned from these experiments that an individual will intentionally seek out an aggressive encounter solely because they experience a rewarding sensation from it,” Kennedy said. “This shows for the first time that aggression, on its own, is motivating, and that the well-known positive reinforcer dopamine plays a critical role.”
Source: Vanderbilt University
Related stories:
Brain rewards aggression much like it does sex, food, drugs
New research from Vanderbilt University shows for the first time that the brain processes aggression as a reward—much like sex, food and drugs—offering insights into our propensity to fight and our fascination with violent sports like boxing and football.
Mice offer clues to the roots of human resilience
When faced with adversity, some people succumb to debilitating psychological diseases including posttraumatic stress disorder and depression, while others are able to remain remarkably optimistic.
Stress: Brain yields clues about why some succumb while others prevail
Results of a new study may one day help scientists learn how to enhance a naturally occurring mechanism in the brain that promotes resilience to psychological stress. Researchers funded by the National Institutes of Health’s National Institute of Mental Health (NIMH) found that, in a mouse model, the ability to adapt to stress is driven by a distinctly different molecular mechanism than is the tendency to be overwhelmed by stress. The researchers mapped out the mechanisms – components of which also are present in the human brain – that govern both kinds of responses.
Immune response to human embryonic stem cells in mice suggests human therapy may face challenge
Human embryonic stem cells trigger an immune response in mice, researchers from the Stanford University School of Medicine report. The finding suggests that the effectiveness of human therapies derived from the cells could be limited unless ways are found to dampen the rejection response.
Scientists find a novel mechanism that controls the development of autoimmunity
Scientists at the National Institutes of Health have found a mechanism in the immune systems of mice that can lead to the development of autoimmune disease when turned off. The findings shed light on the processes that lead to the development of autoimmunity and could also have implications for the development of drugs to increase the immune response in diseases such as cancer and HIV. The study paper appears online today in the journal
Nature.
Vitamin C injections slow tumor growth in mice
High-dose injections of vitamin C, also known as ascorbate or ascorbic acid, reduced tumor weight and growth rate by about 50 percent in mouse models of brain, ovarian, and pancreatic cancers, researchers from the National Institutes of Health (NIH) report in the August 5, 2008, issue of the
Proceedings of the National Academy of Sciences. The researchers traced ascorbate's anti-cancer effect to the formation of hydrogen peroxide in the extracellular fluid surrounding the tumors. Normal cells were unaffected.
Researchers show antibody to breast cancer-secreted protein blocks metastasis
Scientists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have made a key discovery about the mechanism of breast cancer metastasis, the process by which cancer spreads. Focusing on a gene dubbed "Dachshund," or DACH1, they are beginning to pinpoint new therapeutic targets to halt the spread of cancer.
Finding suggests novel ways to boost vaccination or natural defenses
Our bodies rely on the production of potent, or 'high affinity', antibodies to fight infection. The process is very complex, yet Sydney scientists have discovered that it hinges on a single molecule, a growth factor, without which it cannot function.
[Home]
[Full version]